Physicians need to be prepared to talk antibiotics

Physicians need to be prepared to talk antibiotics

(HealthDay)—Patient pressure to receive antibiotic prescriptions remains a challenge for providers who are trying to combat antibiotic resistance by curbing prescriptions for viral infections, according to an article published Jan. 8 in Medical Economics.

The author of the article, Beth Thomas Hertz, notes that the American Academy of Pediatrics Committee on Infectious Diseases recently issued a policy statement, "Principles of Judicious Antibiotic Prescribing for Upper Respiratory Tract Infections in Pediatrics," which provides a framework for clinical decision-making regarding antibiotic use. She says that the report stresses the importance of using defined clinical criteria for diagnosing acute otitis media, acute bacterial sinusitis, and pharyngitis caused by group A Streptococcus, and cautions against the use of antibiotics for indications such as .

Hertz further notes that experts say conversations with patients or their parents regarding not prescribing antibiotics do not have to be contentious. When communicating, be specific about the dangers of and try to confirm specific virus diagnoses in-office. Additionally, experts say, a firm diagnosis of bacterial infection, such as strep, makes the decision about the appropriate use of antibiotics clear.

"Make them feel heard and cared about," suggests Molly Cooke, M.D., president of the American College of Physicians, according to the Medical Economics article. "Replace what they thought they were going to get with other suggestions."

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Black children less likely to be prescribed antibiotics

Mar 18, 2013

(HealthDay)—Black children are less likely to be prescribed antibiotics and to be diagnosed with conditions that require antibiotics, even when treated by the same doctor, according to research published ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments